Recent Therapeutics Policies of Arthritis Rheumatoid (part I)

Oceana Biomedicina Journal

View Publication Info
Field Value
Title Recent Therapeutics Policies of Arthritis Rheumatoid (part I)
Creator Andisari, Hendrata Erry; Hang Tuah University
Description Therapy in RA has undergone many advances today and in line with knowledge of the pathogenesis of RA, the current therapeutic goal is to alter the journey and control the activity of RA disease. Several groups of drugs have been used in RA therapy including non-steroidal anti-inflammatory drugs (NSAIDs), conventional disease-modifying antirheumatic drugs (DMARDs) as well as biological agents (bDMARD), glucocorticoids and anti-pain medicines. In recent years, the development of biological agents that have specific targets for inflammatory mediators such as interleukin (IL) -1, IL-6 and Tumor Necrosis Factor (TNF) suggests a potent therapeutic effect on RA. In this article will be presented the latest biological agents as the latest therapy on RA.
Publisher Universitas Hang Tuah
Date 2018-01-12
Type info:eu-repo/semantics/article
Peer-reviewed Article
Format application/pdf
Source Oceana Biomedicina Journal; Vol 1, No 1 (2018): Oceana Biomedicina Journal; 12-24
Language eng
Rights Copyright (c) 2018 Oceana Biomedicina Journal

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us


Copyright © 2015-2018 Simon Fraser University Library